Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GYPC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | CD244 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | SERPINB1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | GAB3 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | GSDMD | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | APOBR | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | FHL3 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | GBGT1 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | DDO | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |